HomeGNFT • NASDAQ
add
Genfit SA
Previous close
$3.50
Day range
$3.49 - $3.66
Year range
$2.89 - $4.75
Market cap
180.82M USD
Avg Volume
4.57K
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 9.69M | 37.34% |
Operating expense | 15.14M | 11.24% |
Net income | -4.02M | 39.64% |
Net profit margin | -41.51 | 56.05% |
Earnings per share | — | — |
EBITDA | -5.06M | 17.75% |
Effective tax rate | 0.42% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 77.79M | -44.65% |
Total assets | 173.87M | -19.33% |
Total liabilities | 105.92M | -12.47% |
Total equity | 67.95M | — |
Shares outstanding | 49.71M | — |
Price to book | 2.55 | — |
Return on assets | -7.84% | — |
Return on capital | -9.87% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.02M | 39.64% |
Cash from operations | -15.18M | -20.75% |
Cash from investing | -224.00K | 99.03% |
Cash from financing | -1.67M | -80.90% |
Net change in cash | -17.02M | 53.45% |
Free cash flow | -3.82M | 10.97% |
About
Genfit is a French biotechnology company. It's research and clinical trials in the fields of cardiovascular disease and liver disease, especially of metabolic origin. Genfit is also involved in the development of medical diagnostic technology.
It has been listed on the Euronext Paris stock exchange since 2006 and on the NASDAQ since 2019. Wikipedia
Founded
Sep 15, 1999
Website
Employees
159